跳到主要内容

VOLITIONRX LTD (VNRX) Stock Forecast 2025 - AI Price Prediction & Analysis


VOLITIONRX LTD (VNRX) AI Stock Price Forecast & Investment Analysis

VOLITIONRX LTD Stock Price Chart and Technical Analysis

Loading VOLITIONRX LTD interactive price chart and technical analysis...

VOLITIONRX LTD (VNRX) - Comprehensive Stock Analysis & Investment Research

Deep dive into VOLITIONRX LTD's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about VOLITIONRX LTD, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For VOLITIONRX LTD: VOLITIONRX LTD operates in the Life Sciences sector, making it an emerging small-cap investment.

VOLITIONRX LTD (Stock Symbol: VNRX) is a leading company in the Life Sciences sector , specifically operating within the In Vitro & In Vivo Diagnostic Substances industry.

The organization employs approximately 58 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing VOLITIONRX LTD's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For VOLITIONRX LTD: With $1M in annual revenue and -27465.1% net margin, the company demonstrates developing profitability.

Annual Revenue: $1 million generating a -27465.1% net profit margin .

Market Capitalization: $66 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -133.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for VOLITIONRX LTD stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For VOLITIONRX LTD: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for VOLITIONRX LTD stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: VOLITIONRX LTD's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For VOLITIONRX LTD: Market positioning analysis based on available financial and operational metrics.

VOLITIONRX LTD strategically competes in the highly dynamic In Vitro & In Vivo Diagnostic Substances marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

VOLITIONRX LTD (VNRX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for VOLITIONRX LTD stock analysis.

Loading VOLITIONRX LTD comprehensive fundamental analysis and insider trading data...

Deep dive into VOLITIONRX LTD's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if VOLITIONRX LTD stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For VOLITIONRX LTD: With a P/E ratio of 2.71, the market sees the stock as potentially undervalued.

P/E Ratio 2.71x
P/B Ratio -2.52x
Market Cap $66M
EPS $0.06
Book Value/Share $-0.28
Revenue/Share $0.01
FCF/Share $-0.40
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently VOLITIONRX LTD converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For VOLITIONRX LTD: An ROE of -133.9% indicates room for improvement in shareholder value creation.

ROE -133.9%
ROA -78.5%
ROIC -110.0%
Net Margin -27465.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess VOLITIONRX LTD's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For VOLITIONRX LTD: A current ratio of 1.48 shows adequate liquidity.

Current Ratio 1.48x
Quick Ratio 1.36x
D/E Ratio 0.28x
Financial Leverage 2.85x
Interest Coverage -183.8x
Working Capital $14M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal VOLITIONRX LTD's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For VOLITIONRX LTD: Free cash flow of $-12M indicates cash challenges that need attention.

Operating Cash Flow $-12M
Free Cash Flow $-12M
Capital Spending $-1M
CapEx/Sales 343.7%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively VOLITIONRX LTD uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For VOLITIONRX LTD: An asset turnover of 0.01x suggests room for improvement in asset utilization.

Asset Turnover 0.01x
Receivables Turnover 4.1x
Fixed Assets Turnover 0.0x
Days Sales Outstanding 88 days
Understanding Financial Statement Data

What these metrics mean: Key figures from VOLITIONRX LTD's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For VOLITIONRX LTD: With annual revenue of $1M, VOLITIONRX LTD represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $1M
Net Income $-17M
R&D Expense $16M
Cost of Goods Sold $-7M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 82%
Cash & Short-term Investments 75%
Total Liabilities 65%
Short-term Debt 4%
Accounts Receivable 0%
Dividend & Shareholder Information
Shares Outstanding 108M
Growth Metrics (YoY)
EPS Growth 9.2%

Latest VOLITIONRX LTD Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting VOLITIONRX LTD (VNRX) stock price and investment outlook.

, source: Seeking Alpha

VolitionRx, Ltd. has impressive data targeting the Colorectal Cancer screening market with a blood based ELISA test. With the study data already published, VolitionRx, Ltd. is showing stronger ...

, source: CNN

VNRX is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of VNRX shares has decreased $0.03 since the market last closed. This is a 5.18% ...

, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

, source: MarketWatch

VolitionRX Ltd. Annual stock financials by MarketWatch. View the latest VNRX financial statements, income statements and financial ratios.

, source: U.S. News & World Report

What Are Magnificent 7 Stocks? The Magnificent Seven has emerged as a replacement for FAANG stocks.

VOLITIONRX LTD Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of VOLITIONRX LTD against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACHV Unlock Forecast - 30 Days FREE Trial $141M -3.7x 3.4x
AWH Unlock Forecast - 30 Days FREE Trial $2M -0.5x -0.7x
AWHL Unlock Forecast - 30 Days FREE Trial $25M x x
BMRA Unlock Forecast - 30 Days FREE Trial $5M -0.8x 0.9x
BZYR Unlock Forecast - 30 Days FREE Trial $3M x x
CDIO Unlock Forecast - 30 Days FREE Trial $6M -2.3x 0.7x
CDIOW Unlock Forecast - 30 Days FREE Trial $2M x 0.5x
CLDX Unlock Forecast - 30 Days FREE Trial $1623M -10.1x 2.5x
ICCC Unlock Forecast - 30 Days FREE Trial $59M 33.7x 2.0x
IDXX Unlock Forecast - 30 Days FREE Trial $52230M 53.0x 35.8x
IMDX Unlock Forecast - 30 Days FREE Trial $82M x 8.0x
LNTH Unlock Forecast - 30 Days FREE Trial $3796M 14.0x 3.3x
MYGN Unlock Forecast - 30 Days FREE Trial $674M -8.6x 1.7x
NEOG Unlock Forecast - 30 Days FREE Trial $1211M -145.7x 0.5x
NTLA Unlock Forecast - 30 Days FREE Trial $1225M -2.6x 1.6x
OCX Unlock Forecast - 30 Days FREE Trial $81M -0.7x 7.9x
QDEL Unlock Forecast - 30 Days FREE Trial $1934M -1.6x 0.7x
TKNO Unlock Forecast - 30 Days FREE Trial $233M -8.6x 3.1x
TNFA Unlock Forecast - 30 Days FREE Trial $1M -0.2x 0.1x
VNRX Unlock Forecast - 30 Days FREE Trial $66M 2.7x -2.5x

Frequently Asked Questions - VOLITIONRX LTD Stock Forecast

How accurate are VOLITIONRX LTD stock predictions?

Our AI model demonstrates 36% historical accuracy for VNRX predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence VOLITIONRX LTD stock price forecasts?

Our analysis considers VOLITIONRX LTD's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is VOLITIONRX LTD a good investment in 2025?

Based on our AI analysis, VOLITIONRX LTD shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are VOLITIONRX LTD forecasts updated?

VOLITIONRX LTD stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced VOLITIONRX LTD Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for VOLITIONRX LTD stock.

My Portfolio

Investment Dashboard

Loading your portfolio...